Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | CDK1 | P06493 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL939859 | 0.95 | GAA (0.47) | GAACDK1MAPTKMT2ATP53 | |
| Ammonia Solution, Strong SCHEMBL939852 | 0.94 | GAA (0.46) | GAACDK1MAPTKMT2ATP53 | |
| SCHEMBL15244182 | 0.92 | GAA (0.42) | GAACDK1MAPTKMT2ATP53 | |
| Isopropylamine SCHEMBL939850 | 0.91 | GAA (0.43) | GAACDK1MAPTKMT2ATP53 | |
| SCHEMBL15244219 | 0.90 | KMT2A (0.40) | GAAKMT2ATP53ALDH1A1KDM4E | |
| SCHEMBL15695214 | 0.89 | GAA (0.40) | GAACDK1MAPTKMT2ATP53 | |
| SCHEMBL15499805 | 0.89 | GAA (0.40) | GAACDK1MAPTKMT2ATP53 | |
| Monoethanolamine SCHEMBL940690 | 0.89 | GAA (0.42) | GAACDK1MAPTKMT2ATP53 | |
| Diethanolamine SCHEMBL971552 | 0.89 | GAA (0.42) | GAACDK1MAPTKMT2ATP53 | |
| Trolamine SCHEMBL1009951 | 0.89 | GAA (0.42) | GAACDK1MAPTKMT2ATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10544426-B2 | Methods of using ALS inhibitor herbicides for control of unwanted vegetation in ALS inhibitor herbicide tolerant beta vulgaris plants | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2020-01-28 | — | — | US | disclosed |
| US-9686994-B2 | Use of ALS inhibitor herbicides for control of unwanted vegetation in ALS inhibitor herbicide tolerant beta vulgaris plants | BAYER CROPSCIENCE AG (DE) | 2017-06-27 | — | — | US | disclosed |
| US-9686994-B2 | Use of ALS inhibitor herbicides for control of unwanted vegetation in ALS inhibitor herbicide tolerant beta vulgaris plants | BAYER CROPSCIENCE AG (DE) | 2017-06-27 | — | — | US | disclosed |
| US-9370183-B2 | Use of ALS inhibitor herbicides for control of unwanted vegetation in ALS inhibitor herbicide tolerant Brassica, such as B. napus, plants | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2016-06-21 | — | — | US | disclosed |
| US-9370183-B2 | Use of ALS inhibitor herbicides for control of unwanted vegetation in ALS inhibitor herbicide tolerant Brassica, such as B. napus, plants | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2016-06-21 | — | — | US | disclosed |
| US-20150313237-A1 | USE OF ALS INHIBITOR HERBICIDES FOR CONTROL OF UNWANTED VEGETATION IN ALS INHIBITOR HERBICIDE TOLERANT BETA VULGARIS PLANTS | BAYER CROPSCIENCE AG (DE) | 2015-11-05 | — | — | US | disclosed |
| US-20150313237-A1 | USE OF ALS INHIBITOR HERBICIDES FOR CONTROL OF UNWANTED VEGETATION IN ALS INHIBITOR HERBICIDE TOLERANT BETA VULGARIS PLANTS | BAYER CROPSCIENCE AG (DE) | 2015-11-05 | — | — | US | disclosed |
| US-20150089682-A1 | ALS Inhibitor Herbicide Tolerant B. Napus Mutants | BASF AGRICULTURAL SOLUTIONS SEED, US LLC | 2015-03-26 | — | — | US | disclosed |
| US-20150089682-A1 | ALS Inhibitor Herbicide Tolerant B. Napus Mutants | BASF AGRICULTURAL SOLUTIONS SEED, US LLC | 2015-03-26 | — | — | US | disclosed |
| US-20140135219-A1 | USE OF ALS INHIBITOR HERBICIDES FOR CONTROL OF UNWANTED VEGETATION IN ALS INHIBITOR HERBICIDE TOLERANT BRASSICA, SUCH AS B. NAPUS, PLANTS | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-05-15 | — | — | US | disclosed |
| US-20140135219-A1 | USE OF ALS INHIBITOR HERBICIDES FOR CONTROL OF UNWANTED VEGETATION IN ALS INHIBITOR HERBICIDE TOLERANT BRASSICA, SUCH AS B. NAPUS, PLANTS | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-05-15 | — | — | US | disclosed |
| US-20130190179-A1 | USE OF ALS INHIBITOR HERBICIDES FOR CONTROL OF UNWANTED VEGETATION IN ALS INHIBITOR HERBICIDE TOLERANT BETA VULGARIS PLANTS | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-07-25 | — | — | US | disclosed |
| EP-1961305-A1 | Use of sulfonylureas for controlling weeds | Bayer CropScience AG (DE) | 2008-08-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140135219-A1 | USE OF ALS INHIBITOR HERBICIDES FOR CONTROL OF UNWANTED VEGETATION IN ALS INHIBITOR HERBICIDE TOLERANT BRASSICA, SUCH AS B. NAPUS, PLANTS | BROX, HACL2, GLO1 | GAA 30/4885CDK1 2581/4885MAPT 138/4885 |
| US-20150313237-A1 | USE OF ALS INHIBITOR HERBICIDES FOR CONTROL OF UNWANTED VEGETATION IN ALS INHIBITOR HERBICIDE TOLERANT BETA VULGARIS PLANTS | LCT, GLO1, CAT | GAA 15/4885CDK1 1967/4885MAPT 58/4885 |
| US-20130190179-A1 | USE OF ALS INHIBITOR HERBICIDES FOR CONTROL OF UNWANTED VEGETATION IN ALS INHIBITOR HERBICIDE TOLERANT BETA VULGARIS PLANTS | CAT, HTT, GLO1 | GAA 14/4885CDK1 2284/4885MAPT 70/4885 |
| US-10544426-B2 | Methods of using ALS inhibitor herbicides for control of unwanted vegetation in ALS inhibitor herbicide tolerant beta vulgaris plants | LCT, HTT, GLO1 | GAA 32/4885CDK1 2823/4885MAPT 50/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.